| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/07/2002 | US6384192 Amino acid sequence of hedgehog proteins which binds to patched receptor |
| 05/07/2002 | US6384191 Receptors for fibroblast growth factors |
| 05/07/2002 | US6384189 Compositions for stimulating TGF-β activity |
| 05/07/2002 | US6384188 Lipopolysaccharide-binding and neutralizing peptides |
| 05/07/2002 | US6384187 Administering microsclerodermin or salt to mammal as anticarcinogenic and antitumor agent |
| 05/07/2002 | US6384186 Cyclic dodecapeptide and process for the preparation thereof |
| 05/07/2002 | US6384090 Preparation of active ingredient dispersions and apparatus therefor |
| 05/07/2002 | US6384076 Inhibition or erythrocyte sickling by N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester |
| 05/07/2002 | US6384065 Spiro compounds or salts thereof and preventives/remedies for autoimmune diseases and AP-1 inhibitors containing the same |
| 05/07/2002 | US6384022 Enzyme inhibitors |
| 05/07/2002 | US6384017 Methods for treating sex hormone-dependent conditions with Lhrh antagonists |
| 05/07/2002 | US6384016 One peptide selected from glucagon, glp-1, and analogues and derivatives thereof together with a stabilizing and solubilizing amount of at least one detergent, said detergent having at least 2 positive charges, at least 2 negative |
| 05/07/2002 | US6384015 Selective lysis of malaria infected erythrocytes |
| 05/07/2002 | US6384014 Antibiotics as bactericides |
| 05/07/2002 | US6384013 Cyclic peptide antifungal agents and process for preparation thereof |
| 05/07/2002 | US6384012 Use of isolated domains of type IV collagen to modify cell and tissue interactions |
| 05/07/2002 | US6383809 Antisense inhibition of cytohesin-1 expression |
| 05/07/2002 | US6383808 Antisense inhibition of clusterin expression |
| 05/07/2002 | US6383807 Method of transforming T lymphocytes |
| 05/07/2002 | US6383796 Nucleic acids encoding HSKIF21B, a kinesin motor protein |
| 05/07/2002 | US6383793 Human osteoclast-derived cathepsin |
| 05/07/2002 | US6383788 Minimizing thermally induced aggregation of DNase in solution with calcium |
| 05/07/2002 | US6383785 Self-enhancing, pharmacologically controllable expression systems |
| 05/07/2002 | US6383782 Amino acid sequences of monocyte chemoattractant protein-1; antiinflammatory agents; treatment of rheumatoid arthritis, multiple sclerosis and atherosclerosis |
| 05/07/2002 | US6383780 2786, a novel human aminopeptidase |
| 05/07/2002 | US6383779 Glycoprotein VI and uses thereof |
| 05/07/2002 | US6383768 Method for producing in vitro the RNA-dependent RNA polymerase and terminal nucleotidyl transferase activities encoded by hepatitis C virus (HCV) |
| 05/07/2002 | US6383761 Methods and compositions for identifying modulators of G-protein-coupled receptors |
| 05/07/2002 | US6383760 Contacting receptor with test compound, then determining if compound binds to receptor |
| 05/07/2002 | US6383754 Incubating nucleic acid with cleaving reagents, mixing with offset adaptors that couple with nucleic acid fragments, incubating nucleic acids with cleaving reagents that create sticky ends, mixing and coupling adaptor-indexers to fragments |
| 05/07/2002 | US6383744 Human checkpoint kinase |
| 05/07/2002 | US6383739 Drug screening by isolating blood cells then cd8+ cells from donors, culturing with compound for 3 days, culturing in with interleukin-2, detecting immunodeficiency-virus suppressing lymphokine expression, then further analysis |
| 05/07/2002 | US6383738 Herpes simplex virus ORF P is a repressor of viral protein synthesis |
| 05/07/2002 | US6383737 Consisting of a polynucleotide encoding the polypeptide comprising amino acid 1 to 578 of a specific amino acid sequence, a polynucleotide capable of hybridizing to above polynuceotide and a fragment of both polynucleotides |
| 05/07/2002 | US6383733 Methods of screening for pharmacologically active compounds for the treatment of tumour diseases |
| 05/07/2002 | US6383509 Continuous in vivo release of a neurotoxin over a treatment period extending from one month to five years; neurotoxin, especially botulinum toxin or clostridial neurotoxin, within a polymeric matrix |
| 05/07/2002 | US6383498 Neuraminidase and galactose oxidase as vaccine adjuvant |
| 05/07/2002 | US6383496 Recombinant vaccines comprising immunogenic attenuated bacteria having RPOS positive phenotype |
| 05/07/2002 | US6383494 Heat shock proteins |
| 05/07/2002 | US6383493 Methods and compositions for eliciting an immune response with hsp70-peptide complexes |
| 05/07/2002 | US6383492 Treatment of infectious diseases with gp96-peptide complexes |
| 05/07/2002 | US6383491 Prevention of infectious diseases with hsp90-peptide complexes |
| 05/07/2002 | US6383488 Pre-M/M epitopes of dengue virus, synthetic peptides, chimeric proteins and their use |
| 05/07/2002 | US6383487 Antitumor |
| 05/07/2002 | US6383486 Inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 05/07/2002 | US6383485 Method of using anti-phospholipase A2 antibodies to enhance growth or improve feed efficiency |
| 05/07/2002 | US6383483 Anticoagulants |
| 05/07/2002 | US6383480 Composition comprising midkine or pleiotrophin protein and method of increasing hematopoietic cells |
| 05/07/2002 | US6383479 Neutrophil-activating factor |
| 05/07/2002 | US6383478 Polymeric encapsulation system promoting angiogenesis |
| 05/07/2002 | US6383069 Methods and apparatus for performing processing operations on a slaughtered animal or part thereof |
| 05/07/2002 | CA2361071A1 Combination therapies for the stimulation of bone growth |
| 05/07/2002 | CA2175842C Transesterified corn oil products |
| 05/07/2002 | CA1341357C Platelet-specific chimeric immunoglobulin |
| 05/06/2002 | WO2002038178A1 Use of a compound antagonist of the esm-1 protein for producing a medicine for treating cancer |
| 05/06/2002 | CA2429404A1 Use of a compound antagonist of the esm-1 protein for producing a medicine for treating cancer |
| 05/03/2002 | WO2002035962A1 Hair clip |
| 05/03/2002 | CA2377219A1 Hair clip |
| 05/02/2002 | WO2002035240A2 Methods for identifying compounds for regulating muscle mass or function using vasoactive intestinal peptide receptors |
| 05/02/2002 | WO2002035235A2 Net as regulator of angiogenic expression |
| 05/02/2002 | WO2002034934A2 Stresscopins and their uses |
| 05/02/2002 | WO2002034933A2 Methods and compositions for modifying biologically active target molecules |
| 05/02/2002 | WO2002034915A2 Preferred segments of neural thread protein and methods of using the same |
| 05/02/2002 | WO2002034913A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 05/02/2002 | WO2002034912A1 Genomes participating in rheumatoid arthritis, method of the diagnosis thereof, method of evaluating the onset possibility thereof, diagnostic kit for detecting them and therapeutic method and remedies for rheumatoid arthritis |
| 05/02/2002 | WO2002034910A2 Method for modulating granzyme b uptake and for identifying modulators thereof |
| 05/02/2002 | WO2002034904A1 Novel g protein-coupled receptor protein and dna thereof |
| 05/02/2002 | WO2002034900A1 Dipeptidyl peptidases |
| 05/02/2002 | WO2002034899A2 Tec kinase assay |
| 05/02/2002 | WO2002034896A2 13245, a novel human myotonic dystrophy type protein kinase and uses therefor |
| 05/02/2002 | WO2002034895A2 Novel aggrecanase molecules |
| 05/02/2002 | WO2002034887A2 Maturation of dendritic cells |
| 05/02/2002 | WO2002034885A1 Sericin-containing material, process for producing the same and method of using the same |
| 05/02/2002 | WO2002034878A2 Amyloid precursor protein and app-derived peptides inhibit tumor growth and metastasis |
| 05/02/2002 | WO2002034791A2 Methods of purification and recovery of interferon-beta |
| 05/02/2002 | WO2002034786A1 Method of eliminating human serum albumin polymers |
| 05/02/2002 | WO2002034783A2 Transmembrane proteins |
| 05/02/2002 | WO2002034782A2 Endozepine-like polypeptide nov1 and nucleic acid encoding the same |
| 05/02/2002 | WO2002034781A1 Human g-protein coupled diadenosine tetraphosphate receptor (ap4ar) |
| 05/02/2002 | WO2002034779A1 Identification and modification of immunodominant epitopes in polypeptides |
| 05/02/2002 | WO2002034777A1 Fusion proteins as immunization treatments of alzheimer's disease |
| 05/02/2002 | WO2002034776A2 Epitopes of pai-1 |
| 05/02/2002 | WO2002034773A2 Streptococcal genes |
| 05/02/2002 | WO2002034770A1 Identification of hla-dr restricted hcv epitopes |
| 05/02/2002 | WO2002034767A1 Vegf peptides and their use for inhibiting angiogenesis |
| 05/02/2002 | WO2002034766A2 Peptides derived from the human amyloid precursor protein used to protect cells from iron catalyzed oxidative damage |
| 05/02/2002 | WO2002034763A2 Mucin comprising vehicle for the transport of biologically-active agents |
| 05/02/2002 | WO2002034705A2 C-nitroso compounds and use thereof |
| 05/02/2002 | WO2002034303A1 Methods of treating vascular diseases characterized by nitric oxide insufficiency |
| 05/02/2002 | WO2002034296A1 A novel gene therapy agent for haemophilia b and its preparation method |
| 05/02/2002 | WO2002034289A1 Modulating angiogenesis |
| 05/02/2002 | WO2002034286A1 Methods for treating endocrine disorders |
| 05/02/2002 | WO2002034285A2 Treatment of hibernating myocardium and diabetic cardiomyopathy with a glp-1 peptide |
| 05/02/2002 | WO2002034284A2 Methods of therapy for hiv infection |
| 05/02/2002 | WO2002034283A2 Vegh inhibitors and their use |
| 05/02/2002 | WO2002034282A2 Mammary secreted protein 36 (msp36) for cancer treatment and diagnosis |
| 05/02/2002 | WO2002034281A1 Method for promoting hair growth |
| 05/02/2002 | WO2002034280A2 Use of vanilloid 4 receptor and antagonists or agonists thereof for treating diseases associated with pain |
| 05/02/2002 | WO2002034272A2 Methods of improving central nervous system functioning |
| 05/02/2002 | WO2002034248A2 METHOD FOR INCREASING TISSUE PERFUSION BY CO-ADMINISTRATION OF AN AGENT THAT INCREASES cGMP SYNTHESIS AND AN AGENT THAT INHIBITS cGMP DEGRADATION |